Veranova · 12 hours ago
Production Internship Chemical Engineering
West Deptford, NJ
Internship
Onsite
Intern
$20/hr - $22/hrVeranova is a global leader in the development and manufacturing of complex active pharmaceutical ingredients. They are seeking interns for their 2025 Internship Program, which will provide meaningful roles that prepare candidates for their future in pharmaceutical innovation.
BiotechnologyHealth CareManufacturingPharmaceutical
No H1B
Responsibilities
Work closely with production leadership to execute one or two specific projects which they will own from start to finish
Complete a 5S project
Spend time learning how a pharmaceutical manufacturing operation works from raw materials through final product packaged
Carry out any other duties which are within the intern’s skills and abilities whenever reasonably instructed
Qualification
Required
Working towards a BS in Chemical Engineering or Mechanical Engineering or related field
Minimum Overall GPA of 2.7 required
Demonstrated leadership skills with a true career aspiration to be a leader
Must be adaptable, strive for excellence, and demonstrate a positive attitude in the face of adversity
Strong interpersonal skills a must, coupled with a proven ability to build collaborative relationships to achieve results
Proficiency with Microsoft Office required
Strong problem solving and analytical skills essential
Must be legally authorized to work in the US
Benefits
Financial Wellness: We are committed to fair and transparent compensation practices. This includes competitive pay that reflects the scope and expectations of the role.
Professional Development: Opportunities for continuous learning through LinkedIn Learning, workshops, and mentorship.
Inclusive Culture: An inclusive culture is integral to our values. We welcome people with diverse experiences and perspectives who share our mission to improve and save lives.
Company
Veranova
Veranova develops and manufactures active pharmaceutical ingredients(APIs).
Founded in 2022
501-1000 employees
Funding
Current Stage
Late StageTotal Funding
unknown2022-06-01Acquired
Leadership Team
Mike Riley
Chief Executive Officer
Jose Ibietatorremendia
SVP, General Counsel & Secretary
Recent News
2025-08-01
Company data provided by crunchbase